Showing results (271-280 of 861) with videos related to

Sort By:
Pageof 87
Neurology. Clinical Practice|November 16, 2022
Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple SclerosisYinan Zhang, Stacey Cofield, Gary Cutter, et al.
International Journal of Environmental Research and Public Health|May 17, 2020
Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015-2017 PrevalenceMarcello Moccia, Vincenzo Brescia Morra, Roberta Lanzillo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2023
The impact of relapse definition and measures of durability on MS clinical trial outcomesSammita Satyanarayan, Gary Cutter, Stephen Krieger, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2013
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodologyGiancarlo Comi, Mario Alberto Battaglia, Antonio Bertolotto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Validation of the NARCOMS registry: fatigue assessmentRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.
Journal of Neurology|August 21, 2015
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosisLetizia Leocani, Arturo Nuara, Elise Houdayer, et al.
Ebiomedicine|June 24, 2025
Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trialsNoemi Montobbio, Francesca Bovis, Alessio Signori, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Enhancing involvement of people with multiple sclerosis in clinical trial designEmma Gray, Anneesa Amjad, Jenny Robertson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 4, 2012
Clinical epidemiology of ALS in Liguria, ItalyMonica Bandettini di Poggio, Maria Pia Sormani, Romina Truffelli, et al.
Pageof 87